Apr 27, 2022 / 07:30AM GMT
Presentation
Apr 27, 2022 / 07:30AM GMT
=====================
Corporate Participants
=====================
* Hiroyuki Okuzawa
Daiichi Sankyo Company, Limited - Senior Executive Officer, Global Head of Corporate Planning & Management Div., CFO and Director
* Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director
* Wataru Takasaki
Daiichi Sankyo Company, Limited - Executive Officer, Head of R&D Division & VP of Precision Medicine Function
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior
Daiichi Sankyo Co Ltd
(STU:D4S)
€
15.24
+0.27 (+1.79%)
Market Cap: 27.55 Bil
Enterprise Value: 26.18 Bil
PE Ratio: 20.30
PB Ratio: 3.11
GF Score: 74/100 Full Year 2022 Daiichi Sankyo Co Ltd Earnings Presentation Transcript
Apr 27, 2022 / 07:30AM GMT
Release Date Price:
€22.06
(+0.46%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot